TrialClinical and experimental immunology2010

Efficacy and safety of a new immunoglobulin G product, Gammaplex(®), in primary immunodeficiency diseases.

J N Moy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.